ANG Lifesciences P/E Ratio
ANG Lifesciences (ANG) P/E ratio is not applicable — EPS (TTM) ₹-8.43, 8 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has been reporting losses for 8 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.
Consecutive Loss Quarters: 8
Current EPS: ₹-8.43
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -1.07 | -1 | Loss |
| Sept 2025 | -2.24 | -3 | Loss |
| Mar 2025 | -1.56 | -2 | Loss |
| Jun 2025 | -1.52 | -2 | Loss |
| Dec 2025 | -3.60 | -5 | Loss |
| Sept 2024 | -1.53 | -2 | Loss |
| Mar 2024 | -2.75 | -4 | Loss |
| Jun 2024 | -2.35 | -3 | Loss |
Healthcare Peers with Valid P/E Ratios — ANG Comparison
Healthcare sector average P/E 55.26, median 31.04 — ANG excluded (negative EPS).
Sector Average PE
55.26
Sector Median PE
31.04
Lowest PE
2.86
Profitable Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Sunrest Lifescience | SUNREST | 3.65 | ₹29 | Low |
| Phaarmasia | PHRMASI | 3.84 | ₹68 | Low |
| JFL Life Sciences | JFLLIFE | 4.64 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.69 | ₹7,502 | Low |
| Shelter Pharma | SHELTER | 5.32 | ₹50 | Low |
| Mono Pharmacare | MONOPHARMA | 6.02 | ₹19 | Low |
| Royal Sense | ROYAL | 7.4 | ₹51 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹79 | Low |
| Amwill Health Care | AMWILL | 7.71 | ₹88 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see ANG share price screener.
- Read ANG dividend growth for the complete payout history and dividend yield track record.
- See ANG price to book ratio to compare market price against book value per share.